Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -$25.3 million.

  • Caribou Biosciences' Free Cash Flow rose 24.06% to -$25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$127.8 million, marking a year-over-year increase of 2.28%. This contributed to the annual value of -$143.1 million for FY2024, which is 36.39% down from last year.
  • Per Caribou Biosciences' latest filing, its Free Cash Flow stood at -$25.3 million for Q3 2025, which was up 11.77% from -$28.7 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Free Cash Flow high stood at $20.2 million for Q1 2021, and its period low was -$38.7 million during Q1 2024.
  • Its 3-year average for Free Cash Flow is -$30.9 million, with a median of -$33.3 million in 2024.
  • Per our database at Business Quant, Caribou Biosciences' Free Cash Flow tumbled by 212.05% in 2022 and then grew by 26.81% in 2023.
  • Caribou Biosciences' Free Cash Flow (Quarterly) stood at -$22.1 million in 2021, then decreased by 21.41% to -$26.8 million in 2022, then rose by 11.73% to -$23.7 million in 2023, then crashed by 52.13% to -$36.0 million in 2024, then grew by 24.06% to -$25.3 million in 2025.
  • Its last three reported values are -$25.3 million in Q3 2025, -$28.7 million for Q2 2025, and -$37.8 million during Q1 2025.